|
Recently, PerkinElmer announced a new wave of Shanghai Biological Technology Co., Ltd. ("the new wave of biological") acquisition. As an all-cash acquisition, PerkinElmer spend 435 million yuan. This is the second largest Medical Devices Medtronic Inc. 1.7 billion acquisition of Shandong Weigao a 15% stake and set up a joint venture company, yet another M & A in China pharmaceutical companies. PerkinElmer to speed up the pace into the Chinese medical device market It is understood that PerkinElmer is a company focused on the screening business, which in the clinical screening, cytogenetics, maternal and fetal health surveillance in the field, is a global leader. In 2008, the company's global Sell Amounted to 2 billion U.S. dollars. PerkinElmer in Greater China president Daniel? Masak (Daniel R. Marshak) told media that the China business in the global ratio of 5%, about 100 million U.S. dollars. Acquired a new wave of biotechnology companies is the major hospitals in China, especially in areas of infectious diseases related to a major supplier of diagnostic equipment, the product is mainly used for early diagnosis and quantitative detection of hepatitis B, and its related fields market share of the country. The new wave of biological Weidong Xin, general manager, told reporters the company in 2008 sales of 100 million yuan. PerkinElmer chairman, president and CEO, Mr. RobertFriel here, said: "This acquisition accelerates PerkinElmer to enter Chinese medical device market segments, the pace of expansion in China for prenatal and newborn screening services to provide a broader base, while strengthening local PerkinElmer important diagnostic equipment production and R & D base. " China Medicine Rapid warming merger It is reported that since 1999, PerkinElmer through acquisitions, expanding its coverage of screening products. 10 years, the company launched 13 large and small acquisitions. Which is worth noting that in 1999 the company through the acquisition of Finnish Wallac, PerkinElmer laid screening products in the field of this industry. China now exceeds the UK, as the world's fifth largest Drugs Market. With The new medical reform Implementation of related policies and government investment in health care expenditures increase, the Chinese pharmaceutical market by 20% of annual rate of rapid development. In addition, China has more than 6,000 pharmaceutical manufacturers, drug wholesale business on the 10000. Related statistics show that China's market capacity in 2007 Medical Laboratory ~ 80 billion yuan to 70 billion yuan. From 1999 to last year, in addition to Bayer's acquisition of Dongsheng Group "white with black" and other brands, the few big M & A move. But over the past two years as China's pharmaceutical market growth rate rising steadily, as well as local businesses and the sudden emergence in some areas, foreign brands began to choose to acquisitions or joint ventures to enter the Chinese market. It is understood that Sanofi - Aventis, Novartis, GlaxoSmithKline And other global Pharmacy Giants, as well as Philips, GE, Siemens and other medical equipment industry's leading multinational companies are actively looking for domestic high-quality pharmaceutical mergers and acquisitions, as China's new medical reform of the pharmaceutical market, the sharp pull and the gradual strengthening of the Chinese pharmaceutical companies, foreign acquisitions in China the behavior of pharmaceutical companies are just around the corner. The e-commerce company in China offers quality products such as China water drilling equipment , oil drilling rigs, and more. For more , please visit radial drilling machine today!
Related Articles -
China water drilling equipment, oil drilling rigs,
|
